These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 8821653)

  • 1. Effect of context and adjuvant on the immunogenicity of recombinant proteins and peptide conjugates derived from the polymorphic malarial surface antigen MSA2.
    Jones GL; Spencer L; Lord R; Saul AJ
    Vaccine; 1996 Jan; 14(1):77-84. PubMed ID: 8821653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-titer antisera production using three adjuvants and peptide conjugates derived from malarial surface antigen MSA-2.
    Jones GL; Spencer L; Lord R; Edmundson H; Saul AJ
    Pept Res; 1991; 4(3):138-41. PubMed ID: 1823184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic peptide immunogens eliciting antibodies to Plasmodium falciparum sporozoite and merozoite surface antigens in H-2b and H-2k mice.
    Rzepczyk CM; Csurhes PA; Lord R; Matile H
    J Immunol; 1990 Oct; 145(8):2691-6. PubMed ID: 2212657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two immunogenic peptide conjugates derived from P. falciparum MSA2 give rise to antibodies that crossreact with a nonhomologous 195-kDa malarial protein.
    Lord R; Jones G; Saul A
    Pept Res; 1993; 6(4):191-4. PubMed ID: 8400614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological fine structure of the variable and constant regions of a polymorphic malarial surface antigen from Plasmodium falciparum.
    Jones GL; Edmundson HM; Lord R; Spencer L; Mollard R; Saul AJ
    Mol Biochem Parasitol; 1991 Sep; 48(1):1-9. PubMed ID: 1779984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide vaccines derived from a malarial surface antigen: effects of dose and adjuvants on immunogenicity.
    Jones GL; Spencer L; Lord R; Mollard R; Pye D; Saul A
    Immunol Lett; 1990 Jul; 24(4):253-60. PubMed ID: 1697281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amino acid sequences recognized by T cells: studies on a merozoite surface antigen from the FCQ-27/PNG isolate of Plasmodium falciparum.
    Rzepczyk CM; Csurhes PA; Baxter EP; Doran TJ; Irving DO; Kere N
    Immunol Lett; 1990 Aug; 25(1-3):155-63. PubMed ID: 1704345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective immunization with invariant peptides of the Plasmodium falciparum antigen MSA2.
    Saul A; Lord R; Jones GL; Spencer L
    J Immunol; 1992 Jan; 148(1):208-11. PubMed ID: 1727867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative immunogenicity of free and carrier-conjugated peptides derived from the constant regions of a polymorphic malarial surface antigen.
    Jones GL; Lord R; Spencer L; Saul A
    Immunol Lett; 1991 Mar; 27(3):209-14. PubMed ID: 2060972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of a synthetic immunogen: use of the natural immunomodulator polytuftsin in malaria vaccines against RESA antigen of Plasmodium falciparum.
    Pawan K; Ivanov BB; Kabilan L; Rao DN
    Vaccine; 1994 Jul; 12(9):819-24. PubMed ID: 7526572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of an Immunogenic Mimic of a Conserved Epitope on the Plasmodium falciparum Blood Stage Antigen AMA1 Using Virus-Like Particle (VLP) Peptide Display.
    Crossey E; Frietze K; Narum DL; Peabody DS; Chackerian B
    PLoS One; 2015; 10(7):e0132560. PubMed ID: 26147502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variable linking region immunogenicity using malarial peptide carrier protein conjugates of defined composition.
    Jones GL; Spencer L; Mollard R; Saul A
    Immunol Lett; 1990 Dec; 26(3):285-90. PubMed ID: 2086458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of the T cell response to two allelic forms of a malarial vaccine candidate protein.
    Rzepczyk CM; Csurhes PA; Saul AJ; Jones GL; Dyer S; Chee D; Goss N; Irving DO
    J Immunol; 1992 Feb; 148(4):1197-204. PubMed ID: 1371134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipopeptide immunization without adjuvant induces potent and long-lasting B, T helper, and cytotoxic T lymphocyte responses against a malaria liver stage antigen in mice and chimpanzees.
    BenMohamed L; Gras-Masse H; Tartar A; Daubersies P; Brahimi K; Bossus M; Thomas A; Druilhe P
    Eur J Immunol; 1997 May; 27(5):1242-53. PubMed ID: 9174617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Model multiple antigenic and homopolymeric peptides from non-repetitive sequences of malaria merozoite proteins elicit biologically irrelevant antibodies.
    Ramasamy R; Kanagaratnam R; Chandanie PD; Kulachelvy K; Ramasamy MS; Dharmasena PM
    Biochim Biophys Acta; 1999 Jan; 1453(1):115-25. PubMed ID: 9989251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of Plasmodium falciparum and Plasmodium vivax circumsporozoite protein repeat multiple antigen constructs (MAC).
    Udhayakumar V; Saekhou A; Fang S; Jue D; Wohlhueter RM; Lal AA
    Vaccine; 1998; 16(9-10):982-8. PubMed ID: 9682348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of dimorphic and C-terminal fragments of Plasmodium falciparum MSP2 formulated with different adjuvants in mice.
    Balam S; Jafarshad A; Servis C; Frank G; Reed S; Pink R; Druilhe P; Spertini F; Corradin G
    Vaccine; 2016 Mar; 34(13):1566-1574. PubMed ID: 26874325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
    Lalitha PV; Biswas S; Pillai CR; Saxena RK
    Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of well-characterized synthetic Plasmodium falciparum multiple antigen peptide conjugates.
    Joshi MB; Gam AA; Boykins RA; Kumar S; Sacci J; Hoffman SL; Nakhasi HL; Kenney RT
    Infect Immun; 2001 Aug; 69(8):4884-90. PubMed ID: 11447164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of an alum-adsorbed synthetic multiple-antigen peptide based on B- and T-cell epitopes of the Plasmodium falciparum CS protein: possible vaccine application.
    de Oliveira GA; Clavijo P; Nussenzweig RS; Nardin EH
    Vaccine; 1994 Aug; 12(11):1012-7. PubMed ID: 7526570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.